Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

GES-13, a beta-lactamase variant possessing Lys-104 and Asn-170 in Pseudomonas aeruginosa.

Antimicrobial agents and chemotherapy - 1 Mar 2010

Kotsakis S D, Papagiannitsis C C, Tzelepi E, Legakis N J, Miriagou V, Tzouvelekis L S

Abstract excerpt

GES-13 beta-lactamase, a novel GES variant possessing Lys-104 and Asn-170, was identified in Pseudomonas aeruginosa. bla(GES-13) was the single gene cassette of a class 1 integron probably located in the chromosome. GES-13 efficiently hydrolyzed broad-spectrum cephalosporins and aztreonam. Imipen...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Bacterial Agents
Share to beta-Lactamases
Share to beta-Lactams

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cephalosporins

Share to Integrons

Share to Microbial Sensitivity Tests

Share to Pseudomonas aeruginosa

Share to Pseudomonas Infections

Source

Open in PubMed Open full text

Identifiers

PMID: 20065056
DOI: 10.1128/AAC.01561-09
PMCID: PMC2825989

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-20065056-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 9 closest

GES-13, a beta-lactamase variant possessing Lys-104 and Asn-170 in Pseudomonas aeruginosa.PMID 20065056Read ↗

GES-18, a New Carbapenem-Hydrolyzing GES-Type β-Lactamase from Pseudomonas aeruginosa That Contains Ile80 and Ser170 ResiduesSemantic proximity Read ↗

Kinetic and crystallographic studies of extended-spectrum GES-11, GES-12, and GES-14 β-lactamases.Semantic proximity Read ↗

Acquisition of Extended-Spectrum β-Lactamase GES-6 Leading to Resistance to Ceftolozane-Tazobactam Combination in Pseudomonas aeruginosaSemantic proximity Read ↗

Molecular Characterization of a Novel Class 1 Integron Containing <i>bla</i> <sub>GES-1</sub> and a Fused Product of <i>aac(3)-Ib/aac(6</i> " <i>)-Ib</i> " Gene Cassettes in <i>Pseudomonas aeruginosa</i>Semantic proximity Read ↗

Extremely Drug-Resistant <i>Pseudomonas aeruginosa</i> ST309 Harboring Tandem GES Enzymes: A Newly Emerging Threat in the United StatesSemantic proximity Read ↗

Carbapenems as inhibitors of OXA-13, a novel, integron-encoded beta-lactamase in Pseudomonas aeruginosa.Semantic proximity Read ↗

In Vitro Prediction of the Evolution of GES-1 β-Lactamase Hydrolytic ActivitySemantic proximity Read ↗

Novel OXA-10-Derived Extended-Spectrum β-Lactamases Selected In Vivo or In VitroSemantic proximity Read ↗

Kinetic characterization of GES-22 β-lactamase harboring the M169L clinical mutation.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.